Miravitlles M - Search Results

1

Patient's perception of exacerbations of COPD--the PERCEIVE study.

Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M. Miravitlles M, et al. Respir Med. 2007 Mar;101(3):453-60. doi: 10.1016/j.rmed.2006.07.010. Epub 2006 Aug 30. Respir Med. 2007. PMID: 16938447 Free article.

2

Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience.

Miravitlles M, Vidal R, Barros-Tizón JC, Bustamante A, España PP, Casas F, Martínez MT, Escudero C, Jardi R. Miravitlles M, et al. Respir Med. 1998 Oct;92(10):1181-7. doi: 10.1016/s0954-6111(98)90418-8. Respir Med. 1998. PMID: 9926146 Free article.

3

Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.

Miravitlles M, Mayordomo C, Artés M, Sánchez-Agudo L, Nicolau F, Segú JL. Miravitlles M, et al. Respir Med. 1999 Mar;93(3):173-9. doi: 10.1016/s0954-6111(99)90004-5. Respir Med. 1999. PMID: 10464874 Free article.

4

Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group.

Miravitlles M, Murio C, Guerrero T. Miravitlles M, et al. Eur Respir J. 2001 May;17(5):928-33. doi: 10.1183/09031936.01.17509280. Eur Respir J. 2001. PMID: 11488328 Free article.

5

Interpretation of quality of life scores from the St George's Respiratory Questionnaire.

Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, Masa JF, Viejo JL, Jiménez-Ruiz CA, Miravitlles M. Ferrer M, et al. Among authors: miravitlles m. Eur Respir J. 2002 Mar;19(3):405-13. doi: 10.1183/09031936.02.00213202. Eur Respir J. 2002. PMID: 11936515 Free article.

6

Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD.

Miravitlles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group. Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC. Miravitlles M, et al. Chest. 2002 May;121(5):1449-55. doi: 10.1378/chest.121.5.1449. Chest. 2002. PMID: 12006427

7

Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?

Miravitlles M. Miravitlles M. Eur Respir J Suppl. 2002 Jul;36:9s-19s. doi: 10.1183/09031936.02.00400302. Eur Respir J Suppl. 2002. PMID: 12168752 Free article. Review.

8

[Treatment failure of acute exacerbations of chronic obstructive airways disease risk factors and clinical relevance].

Miravitlles M. Miravitlles M. Med Clin (Barc). 2002 Sep 14;119(8):304-14. doi: 10.1016/s0025-7753(02)73396-4. Med Clin (Barc). 2002. PMID: 12236973 Review. Spanish. No abstract available.

9

Costs of chronic bronchitis and COPD: a 1-year follow-up study.

Miravitlles M, Murio C, Guerrero T, Gisbert R. Miravitlles M, et al. Chest. 2003 Mar;123(3):784-91. doi: 10.1378/chest.123.3.784. Chest. 2003. PMID: 12628879

10

[Pharmacoeconomic study of antibiotic therapy for exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in Latin America].

Miravitlles M, Jardim JR, Zitto T, Rodrigues JE, López H. Miravitlles M, et al. Arch Bronconeumol. 2003 Dec;39(12):549-53. doi: 10.1016/s0300-2896(03)75453-2. Arch Bronconeumol. 2003. PMID: 14636491 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

671 results

Search Page

Filters